NA-Semax Amidate 30mg
NA-Semax Amidate is a modified version of Semax with N-terminal acetylation and C-terminal amidation for enhanced metabolic stability. These modifications extend the half-life while maintaining the nootropic, neuroprotective, and BDNF-upregulating properties of the parent Semax peptide.
Sequence
N-Acetyl Semax with C-terminal amidation
Market avg: $69.99 — save 40%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-NASMX-2026-001
Purity
98.9%
Method
HPLC-MS
Batch
NASMX-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
2-8°C, protect from light
Reconstituted
2-8°C, use within 21 days
Enhanced stability version of Semax. N-acetylation and C-terminal amidation increase half-life.
Published Research
1 peer-reviewed studies
Semax activates expression of neurotrophins and their receptors in rat hippocampus
Dolotov OV, Karpenko EA, Inozemtseva LS, et al. — Regulatory Peptides, 2006
Semax neurotrophin upregulation relevant to the enhanced NA-Semax analog.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.